Blog

When the Karen Toffler Charitable Trust first supported Dr. Adithya Gopinath as a Toffler Scholar in 2020, he was a Ph.D. candidate and graduate research assistant in neuroscience at the University of Florida, working in the laboratories of Dr. Habibeh Khoshbouei and Dr. Wolfgang Streit. His research was exploring an intriguing question: Could changes in dopamine signaling in the brain be detected through changes in immune cells elsewhere in the body?

Leading neuroscientist and Alzheimer's disease researcher joins the Trust to help shape the future of brain health research. The Karen Toffler Charitable Trust today announced the appointment of Dr. Bradley T. Hyman to its Advisory Board. Dr. Hyman, the John B. Penney Professor of Neurology at Harvard Medical School and Director of the Massachusetts General Institute for Neurodegenerative Disease

The Karen Toffler Charitable Trust believes that the most important breakthroughs don’t happen in isolation. They emerge when people connect ideas, perspectives, and disciplines in ways others might not see. This year, we are introducing something new and exciting at our annual Exeloop Scholar Event. We are pleased to launch the Future Shock Collaboration Award honoring the legacy of Alvin Toffler and Heidi Toffler

The global research and development (R&D) ecosystem is expanding rapidly, with $1.7 trillion invested worldwide. R&D now involves universities, companies, philanthropies, and nonprofits, not just governments. Scientific capabilities have advanced through artificial intelligence, open data, and worldwide collaboration, but the supporting systems are under stress.

The Karen Toffler Charitable Trust (KTCT) today announced the appointment of Deborah Westphal as its first Chief Executive Officer, marking a significant milestone in the organization’s evolution and long-term vision to advance revolutionizing medical research, education, and technology to combat neurological diseases.

The Karen Toffler Charitable Trust (KTCT) today announced the appointment of Deborah Westphal as its first Chief Executive Officer, marking a significant milestone in the organization’s evolution and long-term vision to advance revolutionizing medical research, education, and technology to combat neurological diseases.